1. Home
  2. QMCO vs KRRO Comparison

QMCO vs KRRO Comparison

Compare QMCO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$13.71

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$14.00

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QMCO
KRRO
Founded
1980
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
150.0M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
QMCO
KRRO
Price
$13.71
$14.00
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$10.50
$34.80
AVG Volume (30 Days)
1.6M
175.0K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$372,827,000.00
$6,392,000.00
Revenue This Year
$0.32
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.65
181.46
52 Week Low
$4.19
$5.20
52 Week High
$18.48
$55.89

Technical Indicators

Market Signals
Indicator
QMCO
KRRO
Relative Strength Index (RSI) 58.14 63.11
Support Level $5.93 $10.02
Resistance Level $15.33 $14.42
Average True Range (ATR) 2.36 1.08
MACD -0.04 0.34
Stochastic Oscillator 28.97 85.61

Price Performance

Historical Comparison
QMCO
KRRO

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: